StemoniX and NCATS to explore the use of microBrain® 3D in advancing new treatments for pain, opioid misuse and addiction as part of the NIH HEAL Initiative MAPLE GROVE, MN – StemoniX® Inc., a biotech company revolutionizing how new medicines are discovered, announced that it entered into a Research Collaboration Agreement with the National Center for Advancing Translational […]
NK-92® Cell Based Bioanalytical Solutions are the Key to Optimizing R&D and Commercial Product Development Efforts for Monoclonal Antibodies, Bi-Specifics and Related Biological Products SAN DIEGO–Brink Biologics, Inc., a NantKwest, Inc. (Nasdaq:NK) affiliate who serves as exclusively-licensed distributor of NantKwest’s proprietary NK-92® natural killer cells, offers a variety of research grade aNK™ and haNK® cell lines for […]
Amendment allows for the development of IVD test kits compatible with Illumina technology TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced it has amended its IVD Test Developmentand Component Supply Agreement with Illumina, Inc. (Illumina), previously amended in June 2017, to enable the expansion of potential fields for […]
Use of Agilent’s custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development SANTA CLARA, Calif., & BOULDER, Colo. Agilent Technologies Inc. (NYSE: A) and SomaLogic, Inc. (a privately held biotechnology company) today announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for […]
Nottingham, UK – 30th April 2019 – NanoFCM Co., Ltd. today announced that it has established a new facility to support existing and potential users of its Nano-Flow Cytometry platform. The Centre of Excellence is located in Medicity, a biotech incubator in Nottingham, UK. It will allow a close interaction with the European scientific community, as […]
REPROCELL USA has achieved ISO9001:2015 accreditation for quality management utilizing the standard operating protocols established over many years by REPROCELL, Japan, BioServe, Stemgent and Biopta. REPROCELL USA will provide quality bio-repository material, stem cell products and offer services related to pre-clinical genomics, stem cell and drug discovery under this certification. BELTSVILLE, MD. By achieving certification […]
MELBOURNE, Australia — MGI, a division of global genomics leader BGI Group, announced that Micromon Genomics is the first Australian commercial user of its high-throughput genetic sequencer MGISEQ-2000. Monash University’s Micromon Genomics, a next-generation sequencing facility located in the university’s Biomedical precinct at the Clayton campus in Melbourne, provides sequencing services to Australian researchers, including DNA, RNA, single cell and […]
This new enzyme-based system allows scientists to accurately and sensitively assess DNA methylation without bisulfite treatment, for epigenetics research. IPSWICH, MA — New England Biolabs (NEB®) today announced the launch of NEBNext® Enzymatic Methyl-seq (EM-seq™), an enzyme-based alternative to bisulfite sequencing for methylation analysis. Bisulfite treatment has long been the gold standard for methylome analysis, specifically […]
Simultaneously Closes Strategic Growth Investment from Ampersand Capital to Create a Leading Provider of Genomic and Cell and Tissue Analysis Products and Services ST. LOUIS — Canopy BiosciencesTM, LLC, a leading provider of gene editing and gene expression products and services, announced today that it has acquired Zellkraftwerk GmbH, a leader in multiplex cytometry. Leveraging […]
LONDON: Freeline, a biotech company focused on developing curative gene therapies for chronic systemic diseases, together with Pall Corporation (Pall), a leading manufacturer of advanced biopharmaceutical processing technology, are pleased to announce the completion of the first full-scale run in Freeline’s newly commissioned Good Manufacturing Practice (GMP) facility located at the Cell and Gene Therapy Catapult […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
